# Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

> **NCT01394029** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 120 (actual)

## Conditions studied

- Transfusional Hemosiderosis

## Interventions

- **DRUG:** deferasirox

## Key facts

- **NCT ID:** NCT01394029
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01394029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01394029, "Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01394029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*